Skip to main content
LLM 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Session VII: T Cell and Hodgkin Lymphomas, and New Ways of Targeting BTK

Thursday, October 19, 2023
1:10 PM - 3:30 PM ET
Location: Metropolitan East

Presentations:

  • 1:10 PM - 1:15 PM ET
    Pre-Session Audience Survey
  • 1:15 PM - 1:25 PM ET
    Presentation of Best Lymphoma Abstract: Mycosis fungoides: Survival outcomes, prognostic factors and sociodemographic characteristics of 6,327 patients in USA

    Abstract Presenter: Henry Becerra Ramirez, MD

  • 1:25 PM - 1:40 PM ET
    The SASS-ARENA Foundation for Medical Research Award: John Ultmann Award for Major Contributions to Lymphoma Research

    Presenter: Morton Coleman, MD – Weill Cornell Medicine

    Award Recipient : Julie Vose, MD, MBA – University of Nebraska Medical Center

  • 1:40 PM - 2:10 PM ET
    Award Lecture:T Cell Lymphomas – How Can We Improve Outcomes beyond Chop?

    Speaker: Julie Vose, MD, MBA – University of Nebraska Medical Center

  • 2:10 PM - 2:30 PM ET
    Current Approaches to Initial Management of Hodgkin Lymphoma

    Speaker: Jonathan W. Friedberg, MD, MMSc – Wilmot Cancer Center, University of Rochester

  • 2:30 PM - 2:50 PM ET
    How I Approach Relapsed Hodgkin Lymphoma

    Speaker: Nancy L. Bartlett, MD – Washington University

  • 2:50 PM - 3:10 PM ET
    BTK Inhibitors for B Cell Lymphomas – Does It Matter Which One You Choose?

    Speaker: Kami J. Maddocks, MD – James Cancer Hospital, Ohio State University

  • 3:10 PM - 3:30 PM ET
    Panel Discussion and Post-Session Audience Survey

    Panelist: Julie Vose, MD, MBA – University of Nebraska Medical Center

    Panelist: Jonathan W. Friedberg, MD, MMSc – Wilmot Cancer Center, University of Rochester

    Panelist: Nancy L. Bartlett, MD – Washington University

    Panelist: Kami J. Maddocks, MD – James Cancer Hospital, Ohio State University